Radiation recall:: A well recognized but neglected phenomenon

被引:159
作者
Azria, D
Magné, N
Zouhair, A
Castadot, P
Culine, S
Ychou, M
Stupp, R
Van Houtte, P
Dubois, JB
Ozsahin, M
机构
[1] Inst Jules Bordet, Dept Radiotherapie, B-1000 Brussels, Belgium
[2] Val dAurelle Paul Lamarque Canc Inst, Dept Radiat Oncol, Montpellier, France
[3] Tumor Immunotargeting & Antibody Engn, EMI 0227, Montpellier, France
[4] CHU Vaudois, Dept Radiat Oncol, CH-1011 Lausanne, Switzerland
[5] Val dAurelle Paul Lamarque Canc Inst, Dept Med Oncol, Montpellier, France
[6] CHU Vaudois, Dept Med Oncol, CH-1011 Lausanne, Switzerland
关键词
dermatitis recall phenomenon; radiation; chemotherapy; side effects; rare cancer network;
D O I
10.1016/j.ctrv.2005.07.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Radiation recall is an inflammatory skin reaction at a previously irradiated field subsequent to the administration of a variety of pharmacologic agents. Although skin has been the major site of radiation recall toxicity, instances involving other organ have been reported. Materials and methods: Data for this review were identified by searches of Medline and Cancerlit. The search terms "radiation", "recall", and "toxicity" were used. References identified from within retrieved articles were also used. There was no limitation on year of publication and no abstract forms were included. Only articles published in English were taken into consideration. Results: Idiosyncratic drug hypersensitivity phenomenon is a recent hypothesis which correlates best with the available facts at this moment. The phenomenon may occur days to years after radiotherapy has been completed. The majority of the drugs commonly used in cancer therapy have been involved in the radiation recall phenomenon. A mixed non-specific inflammatory infiltrate seems to be the common histopathologic criteria in previous published reports. Universally, corticosteroids or the use of non-steroidal anti-inflammatory agents, in conjunction with withdrawal of the offending agent, produce prompt improvement. Conclusion: We propose to collect all future radiation recall phenomenon in a Rare Cancer Network database in order to augment our understanding of this rare reaction. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:555 / 570
页数:16
相关论文
共 87 条
[1]  
Abadir R, 1995, Clin Oncol (R Coll Radiol), V7, P325, DOI 10.1016/S0936-6555(05)80545-X
[2]   Gemcitabine-induced radiation recall dermatitis: Case report [J].
Bar-Sela, G ;
Beny, A ;
Bergman, R ;
Kuten, A .
TUMORI, 2001, 87 (06) :428-430
[3]  
Bokemeyer C, 1996, ANN ONCOL, V7, P755
[4]   Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy -: Histopathologic findings of a patient affected by multiple myeloma [J].
Borroni, G ;
Vassallo, C ;
Brazzelli, V ;
Martinoli, S ;
Ardigò, M ;
Alessandrino, PE ;
Borroni, RC ;
Franchini, P .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2004, 26 (03) :213-216
[5]   Radiation recall -: Another call with tamoxifen [J].
Boström, Å ;
Sjölin-Forsberg, G ;
Wilking, N ;
Bergh, J .
ACTA ONCOLOGICA, 1999, 38 (07) :955-959
[6]   CUTANEOUS COMPLICATIONS OF CHEMOTHERAPEUTIC-AGENTS [J].
BRONNER, AK ;
HOOD, AF .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 9 (05) :645-663
[7]   ADRIAMYCIN-INDUCED RECALL PHENOMENON 15 YEARS AFTER RADIOTHERAPY [J].
BURDON, J ;
BELL, R ;
SULLIVAN, J ;
HENDERSON, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (10) :931-931
[8]   Diagnosis in oncology - Side effects of chemotherapy - Case 1. Radiation recall dermatitis from gemcitabine [J].
Burstein, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :693-694
[9]   Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].
Busam, KJ ;
Capodieci, P ;
Motzer, R ;
Kiehn, T ;
Phelan, D ;
Halpern, AC .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176
[10]  
Camidge DR, 2000, CLIN ONCOL-UK, V12, P272